PsychoGenics offers a wide range of standard and customized preclinical services. PsychoGenics provides a full complement of partnered discovery capabilities focusing on psychiatric and neurodegenerative disorders, pain and inflammation, and spinal cord and traumatic brain injury. PsychoGenics' capabilities include behavioral testing, electrophysiology, molecular biology, and state of the art microdialysis. In addition, the company offers a variety of in-licensed transgenic mouse models. PsychoGenics’ proprietary technologies are developed to facilitate high throughput, in vivo, compound screening.